Bide Pharmatech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	838.11	941.48	1,105	1,274	1,506	193.46
Trading Asset Securities	240.38	100.01	75.52	0.12	3.97	-
Cash & Short-Term Investments	1,078	1,041	1,181	1,274	1,510	193.46
Cash Growth	77.03%	-11.80%	-7.33%	-15.61%	680.49%	43.70%
Accounts Receivable	262.39	261.14	227.37	237.35	177.37	124.68
Other Receivables	12.53	15.17	15.39	10.66	16.79	9.89
Receivables	274.92	276.32	242.76	248.01	194.16	134.57
Inventory	966.6	962.01	760.22	699.43	521.86	476.55
Prepaid Expenses	-	3.64	4.19	5.61	2.47	0.04
Other Current Assets	26.32	21.38	20.7	33.92	16.19	13.1
Total Current Assets	2,346	2,305	2,209	2,261	2,245	817.71
Property, Plant & Equipment	141.34	153.02	166.88	97.32	75.45	60.04
Goodwill	7.56	7.56	-	-	-	-
Other Intangible Assets	4.76	4.93	3.95	0.6	0.21	0.44
Long-Term Deferred Tax Assets	24.47	23.91	14.74	18.36	3.88	2.97
Long-Term Deferred Charges	17.43	19.7	23.74	37.58	16.81	22.13
Other Long-Term Assets	0.24	2.86	-	-	18.25	2.84
Total Assets	2,542	2,517	2,418	2,415	2,359	906.13
Accounts Payable	164.69	202.46	216.32	179.57	167.37	206.07
Accrued Expenses	26.96	44.35	31.38	36.26	30.1	18.57
Short-Term Debt	0.14	0.34	30.18	0.23	9.61	0.07
Current Portion of Long-Term Debt	16.48	4.55	-	-	-	-
Current Portion of Leases	-	14.6	14.06	15.88	-	-
Current Income Taxes Payable	55.75	19.22	12.85	6.49	6.22	8.39
Current Unearned Revenue	46.38	48.31	36.69	29.07	20.52	14.68
Other Current Liabilities	5.52	7.99	4.28	7.47	15.25	1.78
Total Current Liabilities	315.91	341.82	345.76	274.97	249.07	249.56
Long-Term Debt	81	83.25	-	-	-	-
Long-Term Leases	37.8	38.33	37.95	41.19	31.21	27.71
Long-Term Deferred Tax Liabilities	7.38	7.94	7.2	8.06	2.77	-
Other Long-Term Liabilities	0.07	0.07	-	1.27	-	-
Total Liabilities	442.16	471.4	390.91	325.49	283.05	277.27
Common Stock	90.88	90.88	90.88	90.88	64.92	48.69
Additional Paid-In Capital	1,797	1,793	1,755	1,754	1,776	483.24
Retained Earnings	410.34	363.51	289.63	252.08	242.48	96.51
Treasury Stock	-199.98	-199.98	-99.99	-	-	-
Comprehensive Income & Other	1.42	-1.63	-8.6	-6.96	-7.25	0.43
Shareholders' Equity	2,100	2,045	2,027	2,090	2,076	628.86
Total Liabilities & Equity	2,542	2,517	2,418	2,415	2,359	906.13
Total Debt	135.42	141.07	82.2	57.3	40.82	27.78
Net Cash (Debt)	943.08	900.41	1,099	1,217	1,469	165.68
Net Cash Growth	205.24%	-18.04%	-9.72%	-17.17%	786.71%	40.92%
Net Cash Per Share	10.86	10.27	12.35	13.44	19.93	2.47
Filing Date Shares Outstanding	86.72	86.15	88.33	90.88	90.88	68.16
Total Common Shares Outstanding	86.72	86.15	88.33	90.88	90.88	68.16
Working Capital	2,030	1,963	1,863	1,986	1,996	568.15
Book Value Per Share	24.22	23.74	22.95	22.99	22.84	9.23
Tangible Book Value	2,088	2,033	2,023	2,089	2,076	628.42
Tangible Book Value Per Share	24.07	23.60	22.91	22.98	22.84	9.22
Buildings	-	76.58	85.07	16.58	16.58	16.58
Machinery	-	66.68	45.93	47.23	35.62	21.9
Construction In Progress	-	-	15.41	-	5.1	-